Gossamer Bio, Inc.
GOSS
$1.08
-$0.015-1.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 68.56% | 61.77% | 60.90% | 21.82% | 21.61% |
| Total Depreciation and Amortization | -5.34% | -9.33% | -9.99% | -5.39% | -0.99% |
| Total Amortization of Deferred Charges | -17.79% | -9.90% | -1.35% | 3.19% | 13.59% |
| Total Other Non-Cash Items | -71.93% | -31.22% | -35.38% | -28.43% | -27.71% |
| Change in Net Operating Assets | 365.89% | 335.99% | 701.14% | -115.97% | -232.83% |
| Cash from Operations | 97.82% | 99.19% | 97.80% | 15.05% | 14.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 126.15% | 56.20% | -1,798.67% | -11,987.29% | -17,655.20% |
| Cash from Investing | 126.15% | 56.25% | -1,828.69% | -7,815.28% | -10,621.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.34% | -33.33% | -58.33% | -33.34% | -100.02% |
| Issuance of Common Stock | -99.69% | -99.69% | 64.66% | 64.64% | 64.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -106.04% | -107.57% | 65.75% | 67.03% | 62.40% |
| Foreign Exchange rate Adjustments | -192.73% | -60.87% | -105.83% | 91.75% | 121.28% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.49% | 23.60% | 187.02% | 64.22% | -11.71% |